CVTX

CV Therapeutics (CVTX)

CV Therapeutics (MM)

Date:

Regulatory News

Text Search:

Sort by:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:CVTX

<< Previous 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 Next >>

Date	Time	Source	Headline	Symbol	Company
12/07/2007	4:03PM	Edgar (US Regulatory)	CV Therapeutics Inc - Statement of Changes in Beneficial Ownership (4)	NASDAQ:CVTX	CV Therapeutics (MM)
12/07/2007	7:00AM	PR Newswire (US)	FDA Reviewing Potential Anti-Arrhythmic Claims for Ranexa(R)	NASDAQ:CVTX	CV Therapeutics (MM)
12/05/2007	6:08AM	Edgar (US Regulatory)	CV Therapeutics Inc - Current report filing (8-K)	NASDAQ:CVTX	CV Therapeutics (MM)
12/03/2007	3:52PM	Edgar (US Regulatory)	CV Therapeutics Inc - Statement of Ownership (SC 13G)	NASDAQ:CVTX	CV Therapeutics (MM)
11/20/2007	5:24PM	Edgar (US Regulatory)	CV Therapeutics Inc - Current report filing (8-K)	NASDAQ:CVTX	CV Therapeutics (MM)
11/19/2007	4:01PM	PR Newswire (US)	FDA Accepts Ranexa(R) sNDA and NDA for Filing	NASDAQ:CVTX	CV Therapeutics (MM)
11/16/2007	11:45AM	Edgar (US Regulatory)	CV Therapeutics Inc - Current report filing (8-K)	NASDAQ:CVTX	CV Therapeutics (MM)
11/13/2007	5:20PM	Edgar (US Regulatory)	CV Therapeutics Inc (Other) (4)	NASDAQ:CVTX	CV Therapeutics (MM)
11/13/2007	5:20PM	Edgar (US Regulatory)	CV Therapeutics Inc (Other) (4)	NASDAQ:CVTX	CV Therapeutics (MM)
11/13/2007	5:19PM	Edgar (US Regulatory)	CV Therapeutics Inc (Other) (4)	NASDAQ:CVTX	CV Therapeutics (MM)
11/13/2007	5:19PM	Edgar (US Regulatory)	CV Therapeutics Inc (Other) (4)	NASDAQ:CVTX	CV Therapeutics (MM)
11/13/2007	5:18PM	Edgar (US Regulatory)	CV Therapeutics Inc (Other) (4)	NASDAQ:CVTX	CV Therapeutics (MM)
11/13/2007	8:39AM	Edgar (US Regulatory)	CV Therapeutics Inc (Other) (4)	NASDAQ:CVTX	CV Therapeutics (MM)
11/13/2007	6:04AM	Edgar (US Regulatory)	CV Therapeutics Inc (Other)	NASDAQ:CVTX	CV Therapeutics (MM)
11/09/2007	6:09AM	Edgar (US Regulatory)	CV Therapeutics Inc - Quarterly Report (10-Q)	NASDAQ:CVTX	CV Therapeutics (MM)
11/09/2007	6:07AM	Edgar (US Regulatory)	CV Therapeutics Inc - Current report filing (8-K)	NASDAQ:CVTX	CV Therapeutics (MM)
11/08/2007	8:00AM	PR Newswire (US)	CV Therapeutics' Selective Adenosine A1 Agonist Tecadenoson Shows Synergistic Effect with Ultra Low Dose Beta Blocker in Preclin	NASDAQ:CVTX	CV Therapeutics (MM)
11/07/2007	6:05AM	Edgar (US Regulatory)	CV Therapeutics Inc - Current report filing (8-K)	NASDAQ:CVTX	CV Therapeutics (MM)
11/06/2007	4:09PM	Edgar (US Regulatory)	CV Therapeutics Inc - Current report filing (8-K)	NASDAQ:CVTX	CV Therapeutics (MM)
11/06/2007	4:05PM	Edgar (US Regulatory)	CV Therapeutics Inc - Current report filing (8-K)	NASDAQ:CVTX	CV Therapeutics (MM)
11/06/2007	4:00PM	PR Newswire (US)	CV Therapeutics Reports 2007 Third Quarter Financial Results	NASDAQ:CVTX	CV Therapeutics (MM)
11/06/2007	11:00AM	PR Newswire (US)	CV Therapeutics' Anti-Ischemic Agent Ranexa(R) Significantly Reduces HbA1c and Other Markers of Diabetes in MERLIN TIMI-36	NASDAQ:CVTX	CV Therapeutics (MM)
11/06/2007	10:00AM	PR Newswire (US)	Ranexa(R) Significantly Reduces Ischemia in Women in MERLIN TIMI-36 Study	NASDAQ:CVTX	CV Therapeutics (MM)
11/05/2007	3:17PM	Edgar (US Regulatory)	CV Therapeutics Inc - Current report filing (8-K)	NASDAQ:CVTX	CV Therapeutics (MM)
11/05/2007	1:12PM	Edgar (US Regulatory)	CV Therapeutics Inc - Current report filing (8-K)	NASDAQ:CVTX	CV Therapeutics (MM)
11/05/2007	10:00AM	PR Newswire (US)	Ranexa(R) Significantly Reduces Incidence of CV Death, MI or Recurrent Ischemia in MERLIN TIMI-36 Patients With Elevated BNP	NASDAQ:CVTX	CV Therapeutics (MM)
11/02/2007	8:00AM	PR Newswire (US)	Data from Completed Phase 1 Studies of Novel Adenosine A2b Antagonist CVT-6883 Show Safety, Tolerability and Potential Utility i	NASDAQ:CVTX	CV Therapeutics (MM)
10/26/2007	4:10PM	PR Newswire (US)	CV Therapeutics Reports Option Grants Under Nasdaq Marketplace Rule 4350	NASDAQ:CVTX	CV Therapeutics (MM)
10/23/2007	4:01PM	PR Newswire (US)	CV Therapeutics Announces Presentations at American Heart Association Scientific Sessions 2007	NASDAQ:CVTX	CV Therapeutics (MM)
10/11/2007	4:01PM	PR Newswire (US)	CV Therapeutics To Announce 2007 Third Quarter Financial Results on Tuesday, November 6, 2007	NASDAQ:CVTX	CV Therapeutics (MM)